학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 8건 | 목록 1~10
Electronic Resource
Meertens , M , Muntinghe-Wagenaar , M B , Sikkema , B J , Lopez-Yurda , M , Retèl , V P , Paats , M S , Ter Heine , R , Schuuring , E , Timens , W , Touw , D J , van Boven , J F M , de Langen , A J , Hashemi , S M S , Hendriks , L E L , Croes , S , van den Heuvel , M M , Dingemans , A-M C , Mathijssen , R H J , Smit , E F , Huitema , A D R , Steeghs , N & van der Wekken , A J 2023 , ' Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients : Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC) ' , Frontiers in Oncology , vol. 13 , 1136221 .
Academic Journal
This record should be cited as: Gijtenbeek, Rolof GP, Gijtenbeek, Rolof GP, CD013382-cr-0003, Gijtenbeek, Rolof GP, Jong, Kim, Venmans, Ben JW, Vollenhoven, Femke HM, Ten Brinke, Anneke, Van der Wekken, Anthonie J, Geffen, Wouter H. Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status. (Protocol) Cochrane Database of Systematic Reviews 2023, Issue 7. Art. No.: CD013382. DOI: 10.1002/14651858.CD013382.pub2.
검색 결과 제한하기
제한된 항목
[AR] van der Wekken, Anthonie J
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어